Database Query Results : , , UHRF1
UHRF1, Ubiquitin-like with PHD and RING Finger domains 1: Click to Expand ⟱
| Source: |
| Type: |
UHRF1 (Ubiquitin-like with PHD and RING Finger domains 1) is an epigenetic regulator known to be overexpressed in several cancer types. Its altered expression is often associated with poor prognosis.
-UHRF1 is critical for the maintenance of DNA methylation during replication by recruiting DNA methyltransferase 1 (DNMT1) to hemimethylated DNA.
-Evidence suggests that UHRF1 can negatively regulate p53, a key tumor suppressor protein.
-Several studies have linked high UHRF1 expression with the activation of the PI3K/AKT pathway.
|
Scientific Papers found: Click to Expand⟱
TumCCA↑, UHRF1↓, DNMT1↓, p16↑,
ROS⇅, Fas↑, DR5↑, TRAIL↑, Casp3↑, Casp8↑, Casp9↑, P53↑, mTOR↓, Bcl-2↓, BID↓, CXCR4↓, JNK↑, p38↑, MAPK↑, LC3II↑, ATG7↑, Beclin-1↑, AMPK↑, PPARγ↑, eIF2α↓, P70S6K↓, VEGF↓, ERK↓, NF-kB↓, XIAP↓, survivin↓, p65↓, DLC1↑, FOXO↑, TET2↑, CYP1B1↑, UHRF1↓, DNMT1↓, HDAC1↓, IL2↑, IL1↓, IL6↓, IL10↓, IL12↓, TNF-α↓, iNOS↓, COX2↓, 5LO↓, AP-1↓, PI3K↓, Akt↓, cMET↓, VEGFR2↓, CXCL1↓, ITGA5↓, Wnt↓, β-catenin/ZEB1↓, GSK‐3β↓, Myc↓, cycD1/CCND1↓, N-cadherin↓, Snail↓, Slug↓, Vim↓, Twist↓, Zeb1↓, MMP2↓, MMP7↓, MMP9↓, JAK2↓, STAT3↓, NOTCH↓, cycA1/CCNA1↓, CDK2↓, CDK4↓, CDK6↓, CDC2↓, CDC25↓, Mcl-1↓, E2Fs↓, p16↑, p27↑, P21↑, ChemoSen↑,
| - |
in-vitro, |
BC, |
MDA-MB-468 |
|
|
|
- |
in-vitro, |
AML, |
JK |
|
|
|
UHRF1↓, DNMT1↓, DNMT3A↓, DNMTs↓, HDAC1↓, HDAC4↓, HDAC↓, DLC1↑, PPARγ↑, FOXO↑, TET2↑, CYP1B1↑, G9a↓,
DNMT1↓, HDAC1↓, TumCCA↑, ROS↑, Apoptosis↑, angioG↓, TumMeta↓, selectivity↑, BioAv↓, BioAv↓, HDAC1↓, HDAC4↓, UHRF1↓, selectivity↑, G9a↓,
| - |
in-vitro, |
BC, |
MCF-7 |
|
|
|
- |
in-vitro, |
Cerv, |
HeLa |
|
|
|
TumCP↓, Apoptosis↑, UHRF1↓, DNMT1↓, HDAC1↓, eff↝,
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 5
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
ROS↑, 1, ROS⇅, 1,
Mitochondria & Bioenergetics ⓘ
CDC2↓, 1, CDC25↓, 1, XIAP↓, 1,
Core Metabolism/Glycolysis ⓘ
AMPK↑, 1, ATG7↑, 1, PPARγ↑, 2,
Cell Death ⓘ
Akt↓, 1, Apoptosis↑, 2, Bcl-2↓, 1, BID↓, 1, Casp3↑, 1, Casp8↑, 1, Casp9↑, 1, DR5↑, 1, Fas↑, 1, iNOS↓, 1, JNK↑, 1, MAPK↑, 1, Mcl-1↓, 1, Myc↓, 1, p27↑, 1, p38↑, 1, survivin↓, 1, TRAIL↑, 1,
Protein Folding & ER Stress ⓘ
eIF2α↓, 1,
Autophagy & Lysosomes ⓘ
Beclin-1↑, 1, LC3II↑, 1,
DNA Damage & Repair ⓘ
CYP1B1↑, 2, DNMT1↓, 5, DNMT3A↓, 1, DNMTs↓, 1, G9a↓, 2, p16↑, 2, P53↑, 1, UHRF1↓, 5,
Cell Cycle & Senescence ⓘ
CDK2↓, 1, CDK4↓, 1, cycA1/CCNA1↓, 1, cycD1/CCND1↓, 1, E2Fs↓, 1, P21↑, 1, TumCCA↑, 2,
Proliferation, Differentiation & Cell State ⓘ
cMET↓, 1, ERK↓, 1, FOXO↑, 2, GSK‐3β↓, 1, HDAC↓, 1, HDAC1↓, 5, HDAC4↓, 2, mTOR↓, 1, NOTCH↓, 1, P70S6K↓, 1, PI3K↓, 1, STAT3↓, 1, Wnt↓, 1,
Migration ⓘ
5LO↓, 1, AP-1↓, 1, DLC1↑, 2, ITGA5↓, 1, MMP2↓, 1, MMP7↓, 1, MMP9↓, 1, N-cadherin↓, 1, Slug↓, 1, Snail↓, 1, TumCP↓, 1, TumMeta↓, 1, Twist↓, 1, Vim↓, 1, Zeb1↓, 1, β-catenin/ZEB1↓, 1,
Angiogenesis & Vasculature ⓘ
angioG↓, 1, VEGF↓, 1, VEGFR2↓, 1,
Immune & Inflammatory Signaling ⓘ
COX2↓, 1, CXCL1↓, 1, CXCR4↓, 1, IL1↓, 1, IL10↓, 1, IL12↓, 1, IL2↑, 1, IL6↓, 1, JAK2↓, 1, NF-kB↓, 1, p65↓, 1, TNF-α↓, 1,
Hormonal & Nuclear Receptors ⓘ
CDK6↓, 1,
Drug Metabolism & Resistance ⓘ
BioAv↓, 2, ChemoSen↑, 1, eff↝, 1, selectivity↑, 2, TET2↑, 2,
Clinical Biomarkers ⓘ
IL6↓, 1, Myc↓, 1,
Total Targets: 96
Pathway results for Effect on Normal Cells:
Total Targets: 0
Scientific Paper Hit Count for: UHRF1, Ubiquitin-like with PHD and RING Finger domains 1
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1250 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid
Home Page